Pay in 4 interest-free payments of $5.42 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Switching is possible and relatively common in the UK
In clinical trials, tirzepatide produces more weight loss (20-22% at max dose) compared to orforglipron (12.4% at max dose)
Do not inject in the same spot repeatedly, as this can cause lipodystrophy, a condition where fat tissue under the skin becomes lumpy or indented
[9] [14] This reduction occurs gradually over 612 months and appears to be sustained with continued treatment
Even accepting Hims and Hers claim that they are not promoting a prescription weight loss drug, the ad would still fail the FBC Ad Guidelines standard for weight loss/control products because it does not substantiate its claims
US$ 25.28
US$ 29.76
US$ 29.22
US$ 24.16
